Turn Therapeutics Cash Flow Statement (2024-2026) | TTRX

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Sep2024 Dec2024 Mar2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter) -0.67M-0.32M-0.38M-1.91M-2.18M-1.20M
Share-based Compensation (Quarter) 0.04M0.08M0.26M0.16M
Gains from Investment Securities (Quarter) 1.68M1.73M0.04M1.94M
Asset Writedowns and Impairment (Quarter) 0.48M
Non-cash Items (Quarter) 3.88M1.63M8.08M1.63M
Cash from Operations (Quarter) -0.43M-0.30M-1.17M-1.60M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) 0.01M0.01M
Change in Working Capital
Change in Accured Expenses (Quarter) 0.05M-0.02M0.66M-0.61M
Investing Activities
Change in Intangibles (Quarter) 0.01M0.03M0.01M
Cash from Investing Activities (Quarter) -0.01M-0.03M-0.01M
Financing Activities
Change in Capital Stock
Shares Issued (Quarter) 75.00M0.30M3.18M
Misc.
Cash from Financing Activities (Quarter) 0.52M1.00M3.18M7.79M
Change in Cash (Quarter) 0.08M0.70M1.97M6.14M
Free Cash Flow (Quarter) -0.43M-0.30M-1.17M-1.60M
Net Cash Flow (Quarter) 0.08M0.70M1.97M6.17M